Levemir (Insulin Detemir) -


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Levemir (Insulin Detemir)

Only Available By Prescription

Product Size	Retail Price	Our Price
Brand U-100 10mL 1 vial(s)	$113.10	$87.00
Brand Flexpen U-100 3mL x 5 syringes	$201.50	$155.00

For multiple quantities , edit your quantity when you click on checkout or click BUY until you reach your required amount.

Manufacturer: Novo Nordisk
Description Levemir (insulin detemir [rDNA origin] injection) is indicated for once or twice-daily subcutaneous administration for the treatment of adult and pediatric patients with type 1 diabetes mellitus, or adult patients with type 2 diabetes mellitus who require basal (long-acting) insulin for the control of hyperglycemia. Levemir is a long-acting basal insulin that can help patients who need a safe and effective way to improve A1C control. Levemir assists patients to get up to 24-hour control, lower rates of hypoglycemia, cause less weight gain, and maintain consistent blood glucose response rates.
Directions Levemir is not to be used in insulin infusion pumps. Levemir should not be diluted or mixed with any other insulin preparations.
Cautions Hypoglycemia is the most common adverse effect of all insulin therapies, including Levemir. Other adverse events commonly associated with insulin therapy may include injection site reactions such as lipodystrophy, redness, pain, itching, hives, swelling, and inflammation.

*All prices are subject to change without notice and prior to shipping.

	PRODUCT	QTY	PRICE

There are no items in your cart


E-mail:
Password:

New Customer\|Lost Password

E-mail:

All Canadian Prescriptions
Dispensed by:
Newton Pharmacy
604-501-6925

100A - 7455 132nd St.
Surrey, BC
Canada V3W 1J8

Pharmacy Manager:
Robert Lee
License Number 07162

Pharmacist is available from
7am - 4pm PST. Mon-Fri

Licensed by The College of Pharmacists of British Columbia. If you have any questions or concerns you can contact the college at:
200-1765 West 8th Ave Vancouver, BC Canada V6J 5C6

The FDA, due to the current state of their regulations, has taken the position that virtually all shipments of prescription drugs imported from a Canadian pharmacy by a U.S. consumer will violate the law.